Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197

Slides:

Advertisements

Similar presentations

Flow diagram showing study population of Chinese patients with type 2 diabetes mellitus and reasons for exclusion Yang X et al. CMAJ 2008;179:

Advertisements

COHORH STUDY A research paper on BMJ. What is cohort study? Investigates from exposure to outcome, in a group of patients without, or with appropriate.

Modern Management of Cholesterol in the High-Risk Patient.

Appraising Evidence into our Practice. Objectives Deciding the research result into practice in specific context Interpreting/calculating Number Needed.

Laura Mucci, Pharm.D. Candidate Mercer University 2012 Preceptor: Dr. Rahimi February 2012.

Characteristics of new users of statins in the period 1991–2004 in the PHARMO population F.J.A. Penning-van Beest, et al. European Heart Journal 2007;28:154–159.

Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:

Supporting Vascular Risk Assessment: QDScore Julia Hippisley-Cox 15 th April 2010.

Logo Authors & Affiliations : Josep L Clua-Espuny (1), Teresa Forcadell-Arenas (1), Rosa Ripolles-Vicente (1), Panisello-Tafalla(1), Antonia González-Henares.

Baseline Patient Characteristics Bart A.N. Verhoeven, et al. Stroke 2006;37:

Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.

Long-term mortality and thrombolysis therapy after a first acute ischemic stroke: gender differences. Ebrictus II Study. Authors & Affiliations Clua-Espuny.

Baseline Characteristics of the Patients* - Part I The ONTARGET Investigators. N Engl J Med 2008 [Epub on Mar 31]

Process of study selection F. Sofi, et al. BMJ 2008 Sep 11;337:a1344.

Hippisley-Cox J, Coupland C. Heart 2010;96:

When Using DOPPS Slides. DOPPS Slide Use Guidelines.

Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.

Search strategy and results Amir Kashani, et al. Circulation. 2006;114:

Rory M Marks, John Z Ayanian, Brahmajee K Nallamothu

Volume 45, Issue 5, Pages (May 2004)

Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:

Comparison of three Observational Analytical strategies

From: Statins and Cognitive FunctionA Systematic Review

Date:2017/10/03 Presenter: Wen-Ching Lan

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Statin Myopathy (AHA/ACC/NHLBI)

The Anglo Scandinavian Cardiac Outcomes Trial

From: Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular DiseaseGrand Rounds Discussion From the Beth Israel Deaconess Medical.

NAPLEX preparation: Biostatistics

Cardiovascular Disease Risk Reduction Advances in Dyslipidemia

Prospective Cohort Study (Click or press Enter to follow animation)

for the RODAM Consortium

Drug used within 3 months of index date Adjusted odds ratio* p

Baseline characteristics of HPS participants by prior diabetes

TNT Study: Baseline Characteristics of the Patients

US Preventive Services Task Force. Ann Intern Med 2009;150:

Dabigatran vs Warfarin in Patients with Atrial Fibrillation – Results

by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei

Martin Bødtker Mortensen, and Erling Falk JACC 2018;71:85-94

Selmer R, et al. Br J Clin Pharmacol 2009;67:355-62

by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei

Fung TT, et al. Circulation 2009;119:

ASPIRE CLASS 6: Interpreting Results and Writing an Abstract

Statins, Obesity, and Hyperlipidemia

VACS Risk Index Refinement and further validation

Q.A. Truong et al. Circ Cardiovasc Qual Outcomes 2011;4:

Risk for BMI outcome (%)

David M Nathan, MD, James Meigs, MPH, Daniel E Singer, MD The Lancet

Ratio of relative risks of heart disease and stroke associated with higher blood pressure, smoking, type I and II diabetes, and higher cholesterol in women.

by Julia Hippisley-Cox, and Carol Coupland

Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration M. Cushman et al. Circulation. 2005;112:25-31.

Baseline Characteristics

Women’s Health Study: Baseline Characteristics Part 1

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Baseline characteristics of older women (NHS I), younger women (NHS II), and men (HPFS) with a history of hypertension according to thiazide use Eric N.

Brugts JJ, et al. BMJ 2009;338:b2376.

by Julia Hippisley-Cox, and Carol Coupland

We should continue treating on 10 year risk

David J.A. Jenkins et al. JACC 2018;71:

Simvastatin in Patients With Prior Cerebrovascular Disease: HPS

Flow chart of search strategy

Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:

Incidence of gallstone disease in women (top) and men (bottom) per 100 000 person-years. Incidence of gallstone disease in women (top) and men (bottom)

by Julia Hippisley-Cox, and Carol Coupland

Basic statistics.

Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

QRISK 3 – Clare Hawley - Summary slide

Translating Data From Trial to Practice

Presentation transcript:

Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197

Baseline characteristics of study population of new users and non-users of statins Values are numbers (percentages) unless stated otherwise Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197

Crude incidence per 10 000 person years for study outcomes in both men and women Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197

Risk associated with statin type both in men and in women for non-significant and marginal outcomes Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197

Risk of significant outcomes associated with type and dose of statin both in men and in women - Part I Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197

Risk of significant outcomes associated with type and dose of statin both in men and in women - Part II Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197

Relative incidence rate ratios from case series analysis for men and women combined for significant outcomes associated with statin type Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197

Numbers needed to harm (NNH) or numbers needed to treat (NNT) and numbers of extra or prevented cases for each outcome over five years in patients aged 35-74 free of cardiovascular disease at baseline with QRISK2 score of ≥20% or ≥15% Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197